Samia A. Hurst
Research Subjects
Samia A. Hurst has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Alex Mauron
Institute for Biomedical Ethics , Geneva University Medical School
6 shared publicationsAlex Cahana
División de Medicina del Dolor, Universidad de Washington, Seattle, Washington, EEUU
2 shared publicationsA Mauron
1 shared publication- Alex Mauron
Institute for Ethics, History, and the Humanities, Geneva University Medical School, Geneva, Switzerland
1 shared publication - Anne Slowther
Ethox (Oxford Centre for Ethics and Communication in Health Care Practice), Division of Public Health and Primary Care, University of Oxford
1 shared publication - Arnaud Perrier
Department of General Internal Medicine, University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland
1 shared publication
Latest Publications
- 11 June 2010
- Published by Taylor & Francis in AJOB Neuroscience
- Vol. 1 (3) , 18-19
It's Not Who You Are
Anderson-Shaw and colleagues’ focus in their very inter-esting case discussions is that the three patients they de-scribe are no longer the same person as before (2010). Their personal identity has changed. As the authors recog-nize, however, personal identity has several components. So what, exactly, has changed in these patients? It seems to be their character, rather than their physical or psychological continuity—i.e., their numerical identity (Parfit 1984)—or their ability to plan the future. This change in character is sometimes described as simultaneous with the beginning of psychiatric symptoms consecutive to brain surgery for their tumour. Surgery, then, could have a dramatic effect on character. This is presented as problematic
- 11 June 2010
- Published by Taylor & Francis in AJOB Neuroscience
- Vol. 1 (3) , 18-19
It's Not Who You Are
Anderson-Shaw and colleagues’ focus in their very inter-esting case discussions is that the three patients they de-scribe are no longer the same person as before (2010). Their personal identity has changed. As the authors recog-nize, however, personal identity has several components. So what, exactly, has changed in these patients? It seems to be their character, rather than their physical or psychological continuity—i.e., their numerical identity (Parfit 1984)—or their ability to plan the future. This change in character is sometimes described as simultaneous with the beginning of psychiatric symptoms consecutive to brain surgery for their tumour. Surgery, then, could have a dramatic effect on character. This is presented as problematic
- Open Access
- 23 November 2009
- Published by Wiley in Pain Practice
- Vol. 9 (S2) , e15-e21
El Consentimiento Informado Voluntario en la Investigación y la Asistencia Clínica: Una Actualización
Resumen: El consentimiento informado es importante: en la investigación, permite que los sujetos puedan tomar una decisión informada y voluntaria de participar—o de no participar—en un proyecto en el cual se arriesgarán personalmente para beneficio de terceros. Tanto en la investigación como en la asistencia clínica, el consentimiento informado implica consentir que otros intervengan en la esfera privada de un individuo. El consentimiento informado generalmente comprende los elementos de revelación de información, capacidad de decisión, y actuación voluntaria. Para cada elemento existen dificultades y posibles mejoras. Sin embargo, la calidad del consentimiento informado y las estrategias de mejoramiento han sido objeto de investigación sólo recientemente. Este artículo presenta algunos resultados de estos recientes estudios, resumiendo su impacto sobre el consentimiento informado en los ámbitos de la investigación y la asistencia médica. Aunque muchos de los datos sufren de limitaciones, los resultados sugieren que el elemento de revelación de información ha mejorado, aún cuando sigue aplicándose en forma dispareja, a menudo con bajo entendimiento por parte de pacientes y sujetos de investigación. Es más, la confianza es importante para impulsar la participación en ensayos de investigación, de modo que las falsas expectativas, al generar desconfianza, arriesgan el esfuerzo. Aunque el mejoramiento de las planillas de consentimiento no parece tener efecto sobre el entendimiento, el mejoramiento del proceso actual de consentimiento puede tener un impacto positivo. Finalmente, disponiendo de mejor información se puede reducir la ansiedad, con muy poco impacto negativo sobre el nivel de reclutamiento de sujetos.
- 23 November 2009
- Published by Wiley in Pain Practice
- Vol. 9 (S2) , e15-e21
Open AccessEl Consentimiento Informado Voluntario en la Investigación y la Asistencia Clínica: Una Actualización
Resumen: El consentimiento informado es importante: en la investigación, permite que los sujetos puedan tomar una decisión informada y voluntaria de participar—o de no participar—en un proyecto en el cual se arriesgarán personalmente para beneficio de terceros. Tanto en la investigación como en la asistencia clínica, el consentimiento informado implica consentir que otros intervengan en la esfera privada de un individuo. El consentimiento informado generalmente comprende los elementos de revelación de información, capacidad de decisión, y actuación voluntaria. Para cada elemento existen dificultades y posibles mejoras. Sin embargo, la calidad del consentimiento informado y las estrategias de mejoramiento han sido objeto de investigación sólo recientemente. Este artículo presenta algunos resultados de estos recientes estudios, resumiendo su impacto sobre el consentimiento informado en los ámbitos de la investigación y la asistencia médica. Aunque muchos de los datos sufren de limitaciones, los resultados sugieren que el elemento de revelación de información ha mejorado, aún cuando sigue aplicándose en forma dispareja, a menudo con bajo entendimiento por parte de pacientes y sujetos de investigación. Es más, la confianza es importante para impulsar la participación en ensayos de investigación, de modo que las falsas expectativas, al generar desconfianza, arriesgan el esfuerzo. Aunque el mejoramiento de las planillas de consentimiento no parece tener efecto sobre el entendimiento, el mejoramiento del proceso actual de consentimiento puede tener un impacto positivo. Finalmente, disponiendo de mejor información se puede reducir la ansiedad, con muy poco impacto negativo sobre el nivel de reclutamiento de sujetos.
- 18 November 2009
- Vol. 5 (226) , 2366
[So close . . . family and decision making].
- 22 December 2008
- Published by BMJ in Journal of Medical Ethics
- Vol. 35 (1) , 7-11
Just care: should doctors give priority to patients of low socioeconomic status?
Growing data on the socioeconomic determinants of health pose a challenge to analysis and application of fairness in health. InJust health: meeting health needs fairly, Norman Daniels argues for a change in the population end of our thinking about just health. What about clinical care? Given our knowledge of the importance of wealth, education or social status to health, is fairness in medicine served better by continuing to avoid considering our patients’ social status in setting clinical priorities, or by attempting to equalise existing health inequalities by giving priority to the socioeconomically disadvantaged at the point of care? In this article, I argue that doctors should not attempt the latter. Granted, giving priority to low status would go some way towards compensating unjust health inequalities and the impression of being left aside in other social spaces. It would represent reverse discrimination, but could still be justified inasmuch as disadvantaged groups could be identifiable, and as long as the intent was compensation rather than retribution. However, under current circumstances such priority would risk being attributed arbitrarily, would represent a form of medical proselytising, risk leaving the worst-off with less by alienating the powerful, and require teaching doctors to act in strongly counter-cultural ways—possibly at great cost. Crucially, however, we protect both equal health and equal regard by treating all alike: priority to low status would promote the first somewhat, but at the expense of sacrificing the second.
- 22 December 2008
- Published by BMJ in Journal of Medical Ethics
- Vol. 35 (1) , 7-11
Just care: should doctors give priority to patients of low socioeconomic status?
Growing data on the socioeconomic determinants of health pose a challenge to analysis and application of fairness in health. InJust health: meeting health needs fairly, Norman Daniels argues for a change in the population end of our thinking about just health. What about clinical care? Given our knowledge of the importance of wealth, education or social status to health, is fairness in medicine served better by continuing to avoid considering our patients’ social status in setting clinical priorities, or by attempting to equalise existing health inequalities by giving priority to the socioeconomically disadvantaged at the point of care? In this article, I argue that doctors should not attempt the latter. Granted, giving priority to low status would go some way towards compensating unjust health inequalities and the impression of being left aside in other social spaces. It would represent reverse discrimination, but could still be justified inasmuch as disadvantaged groups could be identifiable, and as long as the intent was compensation rather than retribution. However, under current circumstances such priority would risk being attributed arbitrarily, would represent a form of medical proselytising, risk leaving the worst-off with less by alienating the powerful, and require teaching doctors to act in strongly counter-cultural ways—possibly at great cost. Crucially, however, we protect both equal health and equal regard by treating all alike: priority to low status would promote the first somewhat, but at the expense of sacrificing the second.
- 11 November 2008
- Published by Wiley in Pain Practice
- Vol. 8 (6) , 446-451
Voluntary Informed Consent in Research and Clinical Care: An Update
Informed consent is important: in research, it allows subjects to make an informed and voluntary choice to participate—or refuse to participate—in a project where they will be asked to take risks for the benefit of others. In both research and clinical care, informed consent represents a permission to intervene on a person's private sphere. The elements of informed consent are usually described as disclosure, understanding, decision‐making capacity, and voluntariness. Each poses distinct difficulties, and can be amenable to improvements. However, research on the quality of informed consent and on strategies intended to improve it have only become the object of research relatively recently. In this article, we describe some results of this research, and outline how they can be relevant to informed consent in research and clinical care. Although much of the data suffers from limitations, it does suggest that disclosure has improved, but is still uneven, comprehension is often poor, for both patients and research subjects. Moreover, trust is a motivating factor for research participation, and thus we run risks if we allow false expectations and prove ourselves unworthy of this trust. Although improving consent forms does not have a clear effect on understanding, improving the consent process may help. Finally, better information may decrease anxiety and seems to have at most a small negative effect on research recruitment.
- 11 November 2008
- Published by Wiley in Pain Practice
- Vol. 8 (6) , 446-451
Voluntary Informed Consent in Research and Clinical Care: An Update
Informed consent is important: in research, it allows subjects to make an informed and voluntary choice to participate—or refuse to participate—in a project where they will be asked to take risks for the benefit of others. In both research and clinical care, informed consent represents a permission to intervene on a person's private sphere. The elements of informed consent are usually described as disclosure, understanding, decision‐making capacity, and voluntariness. Each poses distinct difficulties, and can be amenable to improvements. However, research on the quality of informed consent and on strategies intended to improve it have only become the object of research relatively recently. In this article, we describe some results of this research, and outline how they can be relevant to informed consent in research and clinical care. Although much of the data suffers from limitations, it does suggest that disclosure has improved, but is still uneven, comprehension is often poor, for both patients and research subjects. Moreover, trust is a motivating factor for research participation, and thus we run risks if we allow false expectations and prove ourselves unworthy of this trust. Although improving consent forms does not have a clear effect on understanding, improving the consent process may help. Finally, better information may decrease anxiety and seems to have at most a small negative effect on research recruitment.
- Open Access
- 1 May 2008
- Published by Springer Nature in EMBO Reports
- Vol. 9 (5) , 402-403
Response by Samia A. Hurst & Alex Mauron
- 1 May 2008
- Published by Springer Nature in EMBO Reports
- Vol. 9 (5) , 402-403
Open AccessResponse by Samia A. Hurst & Alex Mauron
- Top Cited Papers
VULNERABILITY IN RESEARCH AND HEALTH CARE; DESCRIBING THE ELEPHANT IN THE ROOM?
Despite broad agreement that the vulnerable have a claim to special protection, defining vulnerable persons or populations has proved more difficult than we would like. This is a theoretical as well as a practical problem, as it hinders both convincing justifications for this claim and the practical application of required protections. In this paper, I review consent‐based, harm‐based, and comprehensive definitions of vulnerability in healthcare and research with human subjects. Although current definitions are subject to critique, their underlying assumptions may be complementary. I propose that we should define vulnerability in research and healthcare as an identifiably increased likelihood of incurring additional or greater wrong. In order to identify the vulnerable, as well as the type of protection that they need, this definition requires that we start from the sorts of wrongs likely to occur and from identifiable increments in the likelihood, or to the likely degree, that these wrongs will occur. It is limited but appropriately so, as it only applies to special protection, not to any protection to which we have a valid claim. Using this definition would clarify that the normative force of claims for special protection does not rest with vulnerability itself, but with pre‐existing claims when these are more likely to be denied. Such a clarification could help those who carry responsibility for the protection of vulnerable populations, such as Institutional Review Boards, to define the sort of protection required in a more targeted and effective manner.
Top Cited PapersVULNERABILITY IN RESEARCH AND HEALTH CARE; DESCRIBING THE ELEPHANT IN THE ROOM?
Despite broad agreement that the vulnerable have a claim to special protection, defining vulnerable persons or populations has proved more difficult than we would like. This is a theoretical as well as a practical problem, as it hinders both convincing justifications for this claim and the practical application of required protections. In this paper, I review consent‐based, harm‐based, and comprehensive definitions of vulnerability in healthcare and research with human subjects. Although current definitions are subject to critique, their underlying assumptions may be complementary. I propose that we should define vulnerability in research and healthcare as an identifiably increased likelihood of incurring additional or greater wrong. In order to identify the vulnerable, as well as the type of protection that they need, this definition requires that we start from the sorts of wrongs likely to occur and from identifiable increments in the likelihood, or to the likely degree, that these wrongs will occur. It is limited but appropriately so, as it only applies to special protection, not to any protection to which we have a valid claim. Using this definition would clarify that the normative force of claims for special protection does not rest with vulnerability itself, but with pre‐existing claims when these are more likely to be denied. Such a clarification could help those who carry responsibility for the protection of vulnerable populations, such as Institutional Review Boards, to define the sort of protection required in a more targeted and effective manner.
- Open Access
- 1 February 2008
- Published by Springer Nature in EMBO Reports
- Vol. 9 (2) , 119-123
A question of method
- 1 February 2008
- Published by Springer Nature in EMBO Reports
- Vol. 9 (2) , 119-123
Open AccessA question of method
- Open Access
- 31 August 2007
- Published by Springer Nature in BMC Health Services Research
- Vol. 7 (1) , 137
Physicians' views on resource availability and equity in four European health care systems
Background: In response to limited resources, health care systems have adopted diverse cost-containment strategies and give priority to differing types of interventions. The perception of physicians, who witness the effects of these strategies, may provide useful insights regarding the impact of system-wide priority setting on access to care. Methods: We conducted a cross-sectional survey to ascertain generalist physicians' perspectives on resources allocation and its consequences in Norway, Switzerland, Italy and the UK. Results: Survey respondents (N = 656, response rate 43%) ranged in age from 28–82, and averaged 25 years in practice. Most respondents (87.7%) perceived some resources as scarce, with the most restrictive being: access to nursing home, mental health services, referral to a specialist, and rehabilitation for stroke. Respondents attributed adverse outcomes to scarcity, and some respondents had encountered severe adverse events such as death or permanent disability. Despite universal coverage, 45.6% of respondents reported instances of underinsurance. Most respondents (78.7%) also reported some patient groups as more likely than others to be denied beneficial care on the basis of cost. Almost all respondents (97.3%) found at least one cost-containment policy acceptable. The types of policies preferred suggest that respondents are willing to participate in cost-containment, and do not want to be guided by administrative rules (11.2%) or restrictions on hospital beds (10.7%). Conclusion: Physician reports can provide an indication of how organizational factors may affect availability and equity of health care services. Physicians are willing to participate in cost-containment decisions, rather than be guided by administrative rules. Tools should be developed to enable physicians, who are in a unique position to observe unequal access or discrimination in their health care environment, to address these issues in a more targeted way.
- 31 August 2007
- Published by Springer Nature in BMC Health Services Research
- Vol. 7 (1) , 137
Open AccessPhysicians' views on resource availability and equity in four European health care systems
Background: In response to limited resources, health care systems have adopted diverse cost-containment strategies and give priority to differing types of interventions. The perception of physicians, who witness the effects of these strategies, may provide useful insights regarding the impact of system-wide priority setting on access to care. Methods: We conducted a cross-sectional survey to ascertain generalist physicians' perspectives on resources allocation and its consequences in Norway, Switzerland, Italy and the UK. Results: Survey respondents (N = 656, response rate 43%) ranged in age from 28–82, and averaged 25 years in practice. Most respondents (87.7%) perceived some resources as scarce, with the most restrictive being: access to nursing home, mental health services, referral to a specialist, and rehabilitation for stroke. Respondents attributed adverse outcomes to scarcity, and some respondents had encountered severe adverse events such as death or permanent disability. Despite universal coverage, 45.6% of respondents reported instances of underinsurance. Most respondents (78.7%) also reported some patient groups as more likely than others to be denied beneficial care on the basis of cost. Almost all respondents (97.3%) found at least one cost-containment policy acceptable. The types of policies preferred suggest that respondents are willing to participate in cost-containment, and do not want to be guided by administrative rules (11.2%) or restrictions on hospital beds (10.7%). Conclusion: Physician reports can provide an indication of how organizational factors may affect availability and equity of health care services. Physicians are willing to participate in cost-containment decisions, rather than be guided by administrative rules. Tools should be developed to enable physicians, who are in a unique position to observe unequal access or discrimination in their health care environment, to address these issues in a more targeted way.
- 7 March 2007
- Vol. 3 (101) , 630-1
[A single health insurance fund...].